Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Kenyon

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Bone Marrow Transplantation|April 24, 2023
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)Mohamad Mohty, Florent Malard, Ahmed S Alaskar, et al.
Bone Marrow Transplantation|April 22, 2025
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert groupMarion Larue, Florent Malard, Ahmed S Alaskar, et al.
Regulatory Toxicology and Pharmacology : RTP|February 17, 2016
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicityErnst Ahlberg, Alexander Amberg, Lisa D Beilke, et al.
Bone Marrow Transplantation|August 8, 2025
Advancing the Integration of 'Basic/Fundamental' and Translational Cellular and Gene Therapy Science within the EBMT: Accelerating the Pathway to ProgressDonal P McLornan, Mette D Hazenberg, Fabio Ciceri, et al.
Regulatory Toxicology and Pharmacology : RTP|February 16, 2016
Principles and procedures for implementation of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Lisa Beilke, Joel Bercu, et al.
The Lancet. Haematology|October 28, 2023
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMTCarmelo Gurnari, Marie Robin, Lucy A Godley, et al.
Regulatory Toxicology and Pharmacology : RTP|December 19, 2018
Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Roxanne V Andaya, Lennart T Anger, et al.
Blood|March 19, 2025
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMTNicola Polverelli, Juan Carlos Hernandez-Boluda, Francesco Onida, et al.
Bone Marrow Transplantation|March 9, 2023
Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)Riccardo Saccardi, Hein Putter, Dirk-Jan Eikema, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Bone Marrow Transplantation|April 24, 2023
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)Mohamad Mohty, Florent Malard, Ahmed S Alaskar, et al.
Bone Marrow Transplantation|April 22, 2025
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert groupMarion Larue, Florent Malard, Ahmed S Alaskar, et al.
Regulatory Toxicology and Pharmacology : RTP|February 17, 2016
Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicityErnst Ahlberg, Alexander Amberg, Lisa D Beilke, et al.
Bone Marrow Transplantation|August 8, 2025
Advancing the Integration of 'Basic/Fundamental' and Translational Cellular and Gene Therapy Science within the EBMT: Accelerating the Pathway to ProgressDonal P McLornan, Mette D Hazenberg, Fabio Ciceri, et al.
Regulatory Toxicology and Pharmacology : RTP|February 16, 2016
Principles and procedures for implementation of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Lisa Beilke, Joel Bercu, et al.
The Lancet. Haematology|October 28, 2023
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMTCarmelo Gurnari, Marie Robin, Lucy A Godley, et al.
Regulatory Toxicology and Pharmacology : RTP|December 19, 2018
Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analysesAlexander Amberg, Roxanne V Andaya, Lennart T Anger, et al.
Blood|March 19, 2025
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMTNicola Polverelli, Juan Carlos Hernandez-Boluda, Francesco Onida, et al.
Bone Marrow Transplantation|March 9, 2023
Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE)Riccardo Saccardi, Hein Putter, Dirk-Jan Eikema, et al.
Pageof 5